On the same note, GLP1 receptor agonists exhibit multiple pathways of action, displaying multifaceted effects, incorporating HbA1c reduction, increased satiety, calorie intake and bodyweight reduction [28], cardiorenal protection [12,13], and even neuroprotective properties [29], apart from their beneficial effect in NASH and liver steatosis [29,30]. The gene discussed is GLP1R; the disease is Hepatic steatosis.